共 25 条
Molecular basis of macrolide-lincosamide-streptogramin (MLS) resistance in Finegoldia magna clinical isolates
被引:5
作者:
Guerin, Francois
[1
,2
]
Lachaal, Sabrine
[1
]
Auzou, Michel
[1
,2
]
Le Brun, Cecile
[3
]
Barraud, Olivier
[4
]
Decousser, Jean-Winoc
[5
]
Lienhard, Reto
[6
]
Baraduc, Regine
[7
]
Dubreuil, Luc
[8
]
Cattoir, Vincent
[9
,10
]
机构:
[1] CHU Caen, Serv Microbiol, F-14033 Caen, France
[2] Univ Caen Normandie, EA4655 Equipe Antibio Resistance, F-14032 Caen, France
[3] CHRU Tours, Hop Bretonneau, Serv Bacteriol Virol, F-37044 Tours, France
[4] CHU Limoges, Lab Bacteriol Virol Hyg, F-87042 Limoges, France
[5] CHU Henri Mondor, AP HP, Lab Microbiol, F-94010 Creteil, France
[6] ADMED Microbiol, CH-2303 La Chaux De Fonds, Switzerland
[7] CHU Clermont Ferrand, Lab Microbiol, F-63003 Clermont Ferrand, France
[8] CHRU Lille, Lab Bacteriol Hyg & Virol, F-59037 Lille, France
[9] CHU Rennes, Serv Bacteriol & Hyg Hospitaliere, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France
[10] CNR Resistance Antibiot, F-35033 Rennes, France
来源:
关键词:
F.magna;
anaerobes;
GPAC;
MLS;
clindamycin;
erm(A);
erm(B);
POSITIVE ANAEROBIC COCCI;
PEPTOSTREPTOCOCCUS;
SUSCEPTIBILITY;
ELEMENTS;
D O I:
10.1016/j.anaerobe.2020.102220
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Of 69 clinical isolates of Finegoldia magna tested, 36% presented high-level MICs of erythromycin (>256 mu g/ml), harboring erm(A) (n = 20) or erm(B) (n=5). Of nine isolates exhibiting an inducible resistance phenotype to macrolides-lincosamides-streptogramins B, four (44%) were susceptible with a potential risk of treatment failure due to emergence of resistant mutants. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页数:4
相关论文